Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Cell

• Publication date

  1997-03-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0092-8674(00)81902-9PMID 9054499
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis.

  1997cited by this paper
• p53: puzzle and paradigm.

  1996cited by this paper
• Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent

  1996cited by this paper
• The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.

  1996cited by this paper
• Role of the INK4a locus in tumor suppression and cell mortality.

  1996influential reference
• Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation

  1996cited by this paper
• Cdc25 cell-cycle phosphatase as a target of c-myc

  1996cited by this paper
• Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells.

  1996cited by this paper
• Lessons from Hereditary Review Colorectal Cancer

  1996cited by this paper
• HTLV‐1 Tax protein interacts with cyclin‐dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4.

  1996cited by this paper
• Signalling pathways: jack of all cascades.

  1996cited by this paper
• Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts.

  1996cited by this paper
• Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence

  1996cited by this paper
• Genetic analysis of cellular senescence.

  1995cited by this paper
• Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes.

  1995cited by this paper
• Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells

  1995cited by this paper
• Differential growth state‐dependent regulation of plasminogen activator inhibitor type‐1 expression in senescent IMR‐90 human diploid fibroblasts

  1995cited by this paper
• Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors.

  1995cited by this paper
• Cloning and characterization of murine p16INK4a and p15INK4b genes.

  1995cited by this paper
• Origins of G1 arrest in senescent human fibroblasts

  1995cited by this paper
• Inhibition of ras-induced proliferation and cellular transformation by p16INK4

  1995cited by this paper
• The retinoblastoma protein and cell cycle control.

  1995cited by this paper
• Role of the cyclin-dependent kinase inhibitors in the development of cancer.

  1995cited by this paper
• Inhibitors of mammalian G1 cyclin-dependent kinases.

  1995cited by this paper
• Radiation-induced cell cycle arrest compromised by p21 deficiency

  1995cited by this paper
• CDC25 phosphatases as potential human oncogenes.

  1995cited by this paper
• A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

  1995cited by this paper
• Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts

  1995cited by this paper
• Role of Ceramide in Cellular Senescence (*)

  1995cited by this paper
• Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

  1995cited by this paper
• Increased activity of p53 in senescing fibroblasts.

  1995cited by this paper
• A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

  1995cited by this paper
• Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.

  1994cited by this paper
• Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen.

  1994cited by this paper
• Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1.

  1994cited by this paper
• Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

  1994cited by this paper
• Function of a human cyclin gene as an oncogene.

  1994cited by this paper
• Tumor spectrum analysis in p53-mutant mice.

  1994influential reference
• Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells.

  1994cited by this paper
• Overexpression of plasminogen activator inhibitor type‐1 in senescent fibroblasts from normal subjects and those with Werner syndrome

  1994cited by this paper
• Retinoblastoma protein and the cell cycle.

  1993cited by this paper
• The multistep nature of cancer.

  1993cited by this paper
• p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.

  1993cited by this paper
• In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice.

  1993cited by this paper
• Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors.

  1993cited by this paper
• Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis.

  1993cited by this paper
• 老化ヒト二倍体線維芽細胞におけるG1サイクリン調節の変化 不活性サイクリンE‐Cdk2及びサイクリンD1‐Cdk2複合体

  1993cited by this paper
• Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation.

  1993cited by this paper
• Investigation of the role of G1/S cell cycle mediators in cellular senescence.

  1993cited by this paper
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

  1993cited by this paper
• Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes.

  1993cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992cited by this paper
• Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arrest

  1991cited by this paper
• Cooperation between oncogenes.

  1991cited by this paper
• p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts.

  1991cited by this paper
• Differentiation of 3T3-L1 fibroblasts to adipocytes induced by transfection of ras oncogenes.

  1991cited by this paper
• Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

  1990cited by this paper
• Transforming collaborations between ras and nuclear oncogenes.

  1990cited by this paper
• Repression of c-fos transcription and an altered genetic program in senescent human fibroblasts.

  1990cited by this paper
• Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis.

  1989cited by this paper
• Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene.

  1988cited by this paper
• The ras gene family and human carcinogenesis.

  1988cited by this paper
• Ras‐mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation.

  1988cited by this paper
• The in vitro lifespan of MRC-5 cells is shortened by 5-azacytidine-induced demethylation.

  1987cited by this paper
• ras genes.

  1987influential reference
• Strong effects of 5-azacytidine on the in vitro lifespan of human diploid fibroblasts.

  1986cited by this paper
• Microinjection of the ras oncogene protein into nonestablished rat embryo fibroblasts.

  1986cited by this paper
• In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes.

  1986cited by this paper
• Mitogenic effects of the proto-oncogene and oncogene forms of c-H-ras DNA in human diploid fibroblasts

  1986cited by this paper
• Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation.

  1985cited by this paper
• Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture

  1983influential reference
• Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene

  1983cited by this paper
• Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

  1983cited by this paper
• Evidence for a relationship between longevity of mammalian species and life spans of normal fibroblasts in vitro and erythrocytes in vivo.

  1981cited by this paper
• The serial cultivation of human diploid cell strains.

  1961cited by this paper

• Multidimensional mechanisms of quercetin in diabetic kidney disease

  2026cites this paper
• Why isn't an oncogenic mutation in KRAS enough to induce and sustain transformation?

  2026cites this paper
• Towards Precision Oncology: How Advances in Cancer Genomics, Immunobiology and Artificial Intelligence Will Change Molecular Diagnostics

  2026cites this paper
• Senescence at the crossroads of postpartum remodeling and tumorigenesis.

  2026cites this paper
• Atrial myocyte senescence as a driver of atrial fibrillation: mechanisms and therapeutic implications

  2026cites this paper
• Exploratory Biomarker Analysis of Abemaciclib in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma With Dysregulated CDK4/6 Pathway.

  2026cites this paper
• Beyond a gatekeeper: the non-classical signaling role of STRA6 in driving endothelial senescence and atherosclerosis.

  2026cites this paper
• The m⁶A Epitranscriptome: A Regulatory Nexus Linking Cellular Senescence and Oncogenesis.

  2026cites this paper
• Spatial Reorganization of Chromatin Architecture Shapes the Expression Phenotype of Therapy‐Induced Senescent Cells

  2026cites this paper
• Senescent hepatic stellate cells drive inflammation and disease progression in MASH (Review)

  2026cites this paper
• The role of circular RNAs in mediating the protective effects of exercise against muscle degeneration and aging

  2026cites this paper
• p53 increases phospholipid headgroup scavenging in senescence

  2026cites this paper
• Exposure to benzene, toluene and xylenes (BTX) and biological aging: epidemiological evidence from Chinese industrial workers and mechanistic insights.

  2026cites this paper
• Eosinophilic Cells in Endometrial Carcinoma as a Predictor of BRAF Mutation: Report of 2 Cases.

  2026cites this paper
• Cellular senescence in lung cancer immune microenvironment and senotherapeutic opportunities

  2026cites this paper
• The Paradox of Senescence in Glioblastoma: SASP as an Emerging Cancer Hallmark.

  2026cites this paper
• Balancing the Edge: Phosphatases as Homeostatic Buffers of Oncogenic Kinase Signaling in Cancer

  2026cites this paper
• Snail1 Induced Suppression of Proliferation via EGR1, FOXO1, and CEPBγ Creates a Vulnerability for Targeting Apoptotic and Cellular Senescence Pathways

  2026cites this paper
• Senescent Astrocytes: A New Player in Brain Aging and Cognitive Decline

  2026cites this paper
• In the Process.

  2026cites this paper
• Irradiation-induced cellular senescence is linked to pro-survival signaling and checkpoint regulation in a 2D and 3D model for head and neck cancer

  2025cites this paper
• The Role of p53‐Mediated Cellular Senescence in Idiopathic Pulmonary Fibrosis

  2025cites this paper
• Biomarkers of ageing of humans and non-human primates

  2025cites this paper
• Metabolic Profiling of Distinct TP53-Mutant Esophageal Adenocarcinoma Models Reveals Different Bioenergetic Dependencies

  2025cites this paper
• Mechanisms of aging-related secretory phenotype regulation in osteoporosis: Network regulation, trade-offs and homeostasis.

  2025cites this paper
• Senotherapeutics: Milestones, innovations, and future prospects.

  2025cites this paper
• Cellular Senescence: A Pathogenic Driver for Pulmonary Fibrosis.

  2025influential citation
• Immune surveillance of senescent cells in aging and disease

  2025cites this paper
• Impact of the ATM/Chk2 pathway and cell cycle phase on radiation-induced senescence in A549 human lung cancer cells

  2025cites this paper
• Exploring replication stress and cellular senescence as key targets in novel cancer therapies.

  2025cites this paper
• JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms

  2025cites this paper
• Unraveling the effects of FLASH and conventional irradiation on retinal pigment epithelial cells: in vitro and in vivo studies

  2025cites this paper
• Understanding and targeting senescence in kidney disease

  2025cites this paper
• The function of MYC in base excision repair protects against RAS-induced senescence

  2025cites this paper
• Label-Free Detection of Cellular Senescence in Fibroblasts via Third Harmonic Generation

  2025cites this paper
• Oncogenic and tumor-suppressive forces converge on a progenitor-orchestrated niche to shape early tumorigenesis

  2025cites this paper
• Multifaceted regulatory mechanisms of the EGR family in tumours and prospects for therapeutic applications (Review)

  2025cites this paper
• Navigating the Paradox of Senescence and Chemoresistance in Pancreatic Cancer.

  2025cites this paper
• HRasV12 induces apoptosis, not cellular senescence in mouse skeletal myoblasts.

  2025cites this paper
• Senescence, NK cells, and cancer: navigating the crossroads of aging and disease

  2025cites this paper
• A RAS(ON) Multi-Selective Inhibitor Combination Therapy Triggers Long-term Tumor Control through Senescence-Associated Tumor-Immune Equilibrium in Pancreatic Ductal Adenocarcinoma

  2025cites this paper
• Diverse potential of chimeric antigen receptor‐engineered cell therapy: Beyond cancer

  2025cites this paper
• Senolytic Drugs Dasatinib and Quercetin Promote Skin Papilloma Progression by Eliminating Senescent Cells and Impairing Immune Surveillance

  2025cites this paper
• Vascular senescence and aging: mechanisms, clinical implications, and therapeutic prospects

  2025cites this paper
• A transcriptome-based human universal senescence index (hUSI) robustly predicts cellular senescence under various conditions

  2025cites this paper
• NHE7 drives endometrial cancer progression by delaying senescence through cAMP/CREB/GRIN2B axis-mediated Ca²⁺ influx

  2025cites this paper
• Multi-omics dissection of MAPK-driven senescence unveils therapeutic vulnerabilities in KIAA1549::BRAF-fusion pediatric low-grade glioma models

  2025cites this paper
• PSMA5 as a modulator of glioblastoma senescence and prognosis

  2025cites this paper
• O-GlcNAcylation of FOXK1 co-opts BAP1 to orchestrate the E2F pathway and promotes oncogenesis

  2025cites this paper
• KRAS oncogenic mutations in benign tumors: adenomatoid odontogenic tumor as a model.

  2025cites this paper
• Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways

  2025cites this paper
• Characterizing primary and secondary senescence in vivo

  2025cites this paper
• The Molecular Interplay Between p53-Mediated Ferroptosis and Non-Coding RNAs in Cancer

  2025cites this paper
• In vivo modeling of lethal congenital contracture syndrome 1 suggests pathomechanisms in cellular stress responses

  2025cites this paper
• Cabozantinib, an Anti-Aging Agent, Prevents Bone Loss in Estrogen-Deficient Mice by Suppressing Senescence-Associated Secretory Phenotype Factors

  2025cites this paper
• Targeting CyclinD1-CDK6 to Mitigate Senescence-Driven Inflammation and Age-Associated Functional Decline

  2025cites this paper
• Baseline expression of c-Myc defines the tissue specificity of oncogenic K-Ras

  2025cites this paper
• Cardiovascular inflammaging: Mechanisms, consequences, and therapeutic perspectives

  2025cites this paper
• Unraveling the meta-hallmarks between senescent and tumor cells: A new perspective for senolytic drug discovery

  2025cites this paper
• Talazoparib and radiation enhance the senolytic efficacy of venetoclax in therapy-induced senescent triple-negative breast cancer cells

  2025cites this paper
• Cellular senescence in colorectal cancer: its occurrence, effect and therapy

  2025cites this paper
• Redefining senescence through hepatocyte fate changes in liver diseases.

  2025cites this paper
• Current strategies for senescence treatment: Focused on theranostic performance of nanomaterials.

  2025cites this paper
• Therapy-induced senescence is a transient drug resistance mechanism in breast cancer

  2025cites this paper
• Loss of DNA replication fork protection by TIMELESS degradation supports oncogene-induced senescence.

  2025cites this paper
• The Regulation of Cellular Senescence in Cancer

  2025cites this paper
• Detecting Telomeric DNA Damage by Immuno-Telo FISH.

  2025cites this paper
• Kv11.1-dependent senescence activates a lethal immune response via tumor necrosis factor alpha

  2025cites this paper
• Pharmacological Modulation of Cellular Senescence: Implications for Breast Cancer Progression and Therapeutic Strategies.

  2025cites this paper
• A dual-enzyme activated fluorescent probe for precise identification of tumor senescence

  2025cites this paper
• The influence of extracellular vesicles on tumor evolution and resistance to therapy.

  2025cites this paper
• Programmed cell senescence is required for sensory organ development in Drosophila

  2025cites this paper
• Molecular Mechanism of YTHDF2 Inhibiting the Occurrence and Progression of NSCLC

  2025cites this paper
• Exosomal Dynamics: Bridging the Gap Between Cellular Senescence and Cancer Therapy.

  2025cites this paper
• Studying Cellular Senescence Using the Model Organism Drosophila melanogaster.

  2025cites this paper
• Natural Product-Derived Senotherapeutics: Extraction and Biological Evaluation Techniques.

  2025cites this paper
• NLRP10 Cleaves Oxidized DNA inhibited by OGG1 inhibitors: A Newly Identified Role in DNA Damage Processing and Senescence Regulation

  2025cites this paper
• Infrared Imaging Combined with Machine Learning for Detection of the (Pre)Invasive Pancreatic Neoplasia.

  2025cites this paper
• Senescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor control

  2025cites this paper
• Human dermal fibroblast senescence in response to single and recurring oxidative stress

  2025cites this paper
• IFI30 Knockdown Inhibits ESCC Progression by Promoting Apoptosis and Senescence via Activation of JNK and P21/P16 Pathways

  2025cites this paper
• Fisetin and resveratrol exhibit senotherapeuticeffects and suppress cellular senescence in osteoarthritic cartilage-derived chondrogenic progenitor cells.

  2025cites this paper
• Regulation of nucleotide excision repair by wild-type HRAS signaling in head and neck cancer

  2025cites this paper
• A bibliometric and visual analysis of the impact of senescence on tumor immunotherapy

  2025cites this paper
• HIV-Tat upregulates the expression of senescence biomarkers in CD4+ T-cells

  2025cites this paper
• A rare case of intestinal obstruction caused by endometriosis

  2025cites this paper
• TEAD1 condensates are transcriptionally inactive storage sites on the pericentromeric heterochromatin

  2025cites this paper
• The rise of RAS: how gradual oncogene activation shapes the OIS spectrum

  2025cites this paper
• Anti-BCL2 therapy eliminates giant congenital melanocytic nevus by senolytic and immune induction

  2025cites this paper
• Advancing T-cell immunotherapy for cellular senescence and disease: Mechanisms, challenges, and clinical prospects.

  2025cites this paper
• Aging and immunity: the age-old tango

  2025cites this paper
• FOXP1 controls mesenchymal stem cell commitment and senescence during skeletal aging

  2025cites this paper
• Elucidating Ras protein as a dual therapeutic target for inflammation and cancer: a review

  2025cites this paper
• The cGAS-STING axis: a comprehensive review from immune defense to disease pathogenesis

  2025cites this paper
• Tumor-promoting UBR4 coordinates impaired mitophagy–associated senescence and lung adenocarcinoma pathogenesis

  2025cites this paper
• Human fibroblasts from aged individuals exhibit chromosomal instability through replication stress caused by oxidative stress

  2025cites this paper
• Non-genetic mechanisms in cancer evolution: senescence, unicellularization, and cycles of stemness recovery

  2025cites this paper
• Self-amplifying NRF2–EZH2 epigenetic loop converts KRAS-initiated progenitors to invasive pancreatic cancer

  2025cites this paper
• Acetylation in Cardiac Aging: Molecular Mechanism and Therapeutic Approaches.

  2025cites this paper
• Current Methodologies to Assess Cellular Senescence in Cancer.

  2025cites this paper